Why are cystic fibrosis patients prescribed pancreas/viokase/pancreatin?

Patients with cystic fibrosis are prescribed pancreas/viokase/pancreatin because these medications contain digestive enzymes that are essential for nutrient absorption. In cystic fibrosis, thick and sticky mucus can block the pancreatic ducts, preventing enzymes from reaching the intestines where they are needed to properly digest food. Without these enzymes, patients may struggle to absorb fats, proteins, and carbohydrates leading to malnutrition and other gastrointestinal issues.

By supplementing with these enzymes, cystic fibrosis patients can improve their ability to digest food effectively, allowing for better nutrient intake and overall health. This therapeutic approach addresses a critical aspect of managing the disease, as proper nutrition plays a significant role in growth and development, particularly during childhood and adolescence.